|
LOC285359 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.08370000043656E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.203490E-04 |
| Normal-vs-Stage2 |
1.141800E-01 |
| Normal-vs-Stage3 |
1.848170E-04 |
| Normal-vs-Stage4 |
1.584870E-03 |
| Stage1-vs-Stage2 |
6.077600E-01 |
| Stage1-vs-Stage3 |
5.526800E-01 |
| Stage1-vs-Stage4 |
4.481000E-01 |
| Stage2-vs-Stage3 |
3.723600E-01 |
| Stage2-vs-Stage4 |
3.430200E-01 |
| Stage3-vs-Stage4 |
8.136600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.426700E-04 |
| Normal-vs-AfricanAmerican |
2.60279999775292E-08 |
| Normal-vs-Asian |
1.922440E-03 |
| Caucasian-vs-AfricanAmerican |
1.9350899999937E-05 |
| Caucasian-vs-Asian |
3.787800E-04 |
| AfricanAmerican-vs-Asian |
7.774200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.939100E-03 |
| Normal-vs-Female |
2.37910002809372E-09 |
| Male-vs-Female |
1.198800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.021160E-01 |
| Normal-vs-Age(41-60Yrs) |
4.71719999950437E-07 |
| Normal-vs-Age(61-80Yrs) |
1.224430E-03 |
| Normal-vs-Age(81-100Yrs) |
2.665200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.802600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.421400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.879800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.088300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.214200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.624000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.083600E-02 |
| Normal-vs-Grade 2 |
5.81469999999529E-05 |
| Normal-vs-Grade 3 |
9.69429999999605E-05 |
| Normal-vs-Grade 4 |
1.132260E-02 |
| Grade 1-vs-Grade 2 |
4.786800E-01 |
| Grade 1-vs-Grade 3 |
3.667200E-01 |
| Grade 1-vs-Grade 4 |
3.338400E-01 |
| Grade 2-vs-Grade 3 |
7.749400E-01 |
| Grade 2-vs-Grade 4 |
6.719000E-01 |
| Grade 3-vs-Grade 4 |
8.088400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.84039999998154E-06 |
| Normal-vs-ccB subtype |
5.256100E-02 |
| ccA subtype-vs-ccB subtype |
7.140900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.015200E-04 |
| Normal-vs-N1 |
1.996440E-01 |
| N0-vs-N1 |
7.911600E-01 |
|
|
